, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Non-specific inhibition of human cytochrome P450-catalyzed reactions by hemin.

Kim EY, Kim JS, Kim MY, Koh WS, Guengerich FP, Yun CH
Toxicol Lett. 2004 153 (2): 239-46

PMID: 15451555 · DOI:10.1016/j.toxlet.2004.04.017

Hemin, a stable form of heme, is known to have an antimutagenic effect. Inhibitory effects of hemin on the cytochrome P450 (CYP)-catalyzed reactions of human liver microsomes and reconstituted systems containing purified CYP and NADPH-cytochrome P450 reductase (NPR) were seen. Hemin non-specifically inhibited all of the microsomal CYP activities examined. Hemin also inhibited 7-ethoxyresorufin O-deethylation, 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin O-demethylation, and testosterone 6beta-hydroxylation catalyzed by purified CYPs 1A2, 2D6, and 3A4, with IC50 values of 27, 19, and 2.4 microM, respectively. Hemin also inhibited reduction of cytochrome c and ferricyanide by NPR, as much as 47%. Spectrally detectable CYP was destroyed in human liver microsomes and in a reconstituted system in the presence of hemin and an NADPH-generating system. We propose that the antimutagenic effect of hemin might be due to inhibition of CYP and NPR enzymes involved in the bioactivation of mutagens.

MeSH Terms (7)

Catalysis Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Hemin Humans Microsomes, Liver NADPH-Ferrihemoprotein Reductase

Connections (1)

This publication is referenced by other Labnodes entities:

Links